Arcudi III Louis J 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Nov 15, 2012
Insider Transaction Report
Form 4
Arcudi III Louis J
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-11-13+33,500→ 146,000 totalExercise: $1.16Exp: 2021-11-28→ Common Stock (33,500 underlying)
Footnotes (1)
- [F1]On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 200,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On November 13, 2012, certain performance vesting criteria were met with respect to 33,500 of such shares, of which 8,375 shares vested on November 13, 2012 and the remaining 25,125 of which will vest in three equal annual installments beginning on November 13, 2013.